• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血细胞移植后影响T淋巴细胞生成的因素。

Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation.

作者信息

Storek Jan, Joseph Ansamma, Dawson Monja A, Douek Daniel C, Storer Barry, Maloney David G

机构信息

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

Transplantation. 2002 Apr 15;73(7):1154-8. doi: 10.1097/00007890-200204150-00026.

DOI:10.1097/00007890-200204150-00026
PMID:11965050
Abstract

In adult recipients of allogeneic hematopoietic cell transplants (HCT) studied at 1 year after grafting, there was a significant correlation between the counts of T cell receptor excision circle (TREC)-containing CD4 T cells (presumed recent thymic emigrants) and the counts of total T cells (r=0.65, P<0.001). Thus, the reconstitution of CD4 T cell pool depends on T cell generation from hematopoietic stem cells (T-lymphopoiesis). We evaluated factors that could affect T-lymphopoiesis. Low TREC-containing CD4 T cell counts were associated with older patient age (r=-0.41, P=0.01) but not with donor age, graft type (marrow vs. blood stem cells), CD34 cell dose, conditioning (with vs. without irradiation), acute graft-versus-host disease (aGVHD), or chronic graft-versus-host disease (cGVHD) in multivariate analysis. We conclude that patient age is the primary determinant of CD4 T-lymphopoiesis after allogeneic HCT.

摘要

在移植后1年进行研究的异基因造血细胞移植(HCT)成年受者中,含有T细胞受体切除环(TREC)的CD4 T细胞(推测为近期胸腺迁出细胞)计数与总T细胞计数之间存在显著相关性(r = 0.65,P < 0.001)。因此,CD4 T细胞库的重建依赖于造血干细胞产生T细胞(T淋巴细胞生成)。我们评估了可能影响T淋巴细胞生成的因素。在多变量分析中,含有TREC的CD4 T细胞计数低与患者年龄较大相关(r = -0.41,P = 0.01),但与供者年龄、移植物类型(骨髓与造血干细胞)、CD34细胞剂量、预处理(有或无照射)、急性移植物抗宿主病(aGVHD)或慢性移植物抗宿主病(cGVHD)无关。我们得出结论,患者年龄是异基因HCT后CD4 T淋巴细胞生成的主要决定因素。

相似文献

1
Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后影响T淋巴细胞生成的因素。
Transplantation. 2002 Apr 15;73(7):1154-8. doi: 10.1097/00007890-200204150-00026.
2
Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.急性移植物抗宿主病会短暂损害年轻患者异基因造血干细胞移植后的胸腺输出。
Blood. 2009 Jun 18;113(25):6477-84. doi: 10.1182/blood-2008-09-176594. Epub 2009 Mar 3.
3
[The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].[CD4+CD25+T细胞及FOXP3在同种异体肝移植急性排斥反应中的作用] (注:原文中“hsot”可能有误,推测为“同种异体肝移植”“homologous liver transplantation”的相关错误表述,这里根据正确理解翻译)
Zhonghua Nei Ke Za Zhi. 2006 Oct;45(10):835-8.
4
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.无关供者状态和供者高龄独立影响非清髓性预处理后的免疫恢复。
Biol Blood Marrow Transplant. 2006 Nov;12(11):1176-87. doi: 10.1016/j.bbmt.2006.07.004.
5
Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.与异基因人类干细胞移植后慢性髓性白血病患者体内初始T细胞的存在以及慢性移植物抗宿主病和复发的较低发生率相关。
Transplant Proc. 2007 Nov;39(9):2898-901. doi: 10.1016/j.transproceed.2007.08.036.
6
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.影响异基因造血细胞移植受者T细胞区室重建的因素。
Bone Marrow Transplant. 2003 Nov;32(10):1001-14. doi: 10.1038/sj.bmt.1704235.
7
Altered thymic CD4 T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis.异基因造血干细胞移植后胸腺 CD4 T 细胞恢复的改变对诺卡氏菌病至关重要。
Curr Res Transl Med. 2019 Nov;67(4):135-143. doi: 10.1016/j.retram.2019.05.001. Epub 2019 Jun 1.
8
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.多发性骨髓瘤、慢性髓性白血病和急性髓性白血病患者外周血干细胞异基因移植后的不同免疫重建情况。
Bone Marrow Transplant. 2000 Dec;26(12):1325-31. doi: 10.1038/sj.bmt.1702709.
9
Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.B细胞和T细胞免疫重建改变先于慢性移植物抗宿主病临床症状出现,并受发病类型影响。
Ann Hematol. 2017 Feb;96(2):299-310. doi: 10.1007/s00277-016-2881-x. Epub 2016 Dec 9.
10
Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.供者白细胞介素-7 受体α链基因型预测异基因造血干细胞移植后移植物抗宿主病和巨细胞病毒感染的风险。
Front Immunol. 2018 Feb 2;9:109. doi: 10.3389/fimmu.2018.00109. eCollection 2018.

引用本文的文献

1
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults.造血细胞移植后T细胞恢复延迟与成人总体生存率降低有关。
Blood Adv. 2025 Jul 22;9(14):3502-3517. doi: 10.1182/bloodadvances.2024015288.
2
The potential role of the thymus in immunotherapies for acute myeloid leukemia.胸腺在急性髓系白血病免疫治疗中的潜在作用。
Front Immunol. 2023 Feb 6;14:1102517. doi: 10.3389/fimmu.2023.1102517. eCollection 2023.
3
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities.
异基因干细胞移植治疗急性髓系白血病:障碍与机遇概述
World J Clin Cases. 2023 Jan 16;11(2):268-291. doi: 10.12998/wjcc.v11.i2.268.
4
Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection.化疗后胸腺反应性增生被误诊为纵隔受累淋巴瘤患者的疾病进展:病例报告及反思。
BMC Surg. 2021 Jan 14;21(1):38. doi: 10.1186/s12893-021-01048-y.
5
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 1 年的 T 细胞受体遗传多样性。
Leukemia. 2020 May;34(5):1422-1432. doi: 10.1038/s41375-019-0654-y. Epub 2019 Nov 26.
6
Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation.流式细胞术评估造血干细胞移植后免疫重建
Front Immunol. 2018 Jul 26;9:1672. doi: 10.3389/fimmu.2018.01672. eCollection 2018.
7
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后的免疫重建
Front Immunol. 2016 Nov 17;7:507. doi: 10.3389/fimmu.2016.00507. eCollection 2016.
8
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.慢性移植物抗宿主病生物学:美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目的一份特别工作组报告。
Biol Blood Marrow Transplant. 2017 Feb;23(2):211-234. doi: 10.1016/j.bbmt.2016.09.023. Epub 2016 Oct 3.
9
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.巨细胞病毒再激活驱动移植后T细胞重建,并导致潜在的TCRβ库出现缺陷。
Blood. 2015 Jun 18;125(25):3835-50. doi: 10.1182/blood-2015-03-631853. Epub 2015 Apr 7.
10
An anti-human thymocyte globulin-based reduced-intensity conditioning regimen is associated with a higher quality of life and lower organ toxicity without affecting lymphocyte reconstitution.基于抗人胸腺细胞球蛋白的低强度预处理方案与更高的生活质量和更低的器官毒性相关,而不影响淋巴细胞重建。
PLoS One. 2013 Sep 9;8(9):e73755. doi: 10.1371/journal.pone.0073755. eCollection 2013.